Digital Innovation Index
This annual index reveals how the top companies are leveraging digital advancements to accelerate development, improve patient engagement, and drive impactful change in healthcare.
2024 Digital Innovation Index
The 2025 results will launch on the 4th of November live at the Collaborating for Novel Solutions (CNS) Summit in Boston.
-
- Roche 1
- 2023 2nd
- 2022 1st
- 1
- AstraZeneca 1
- 2023 1st
- 2022 10th
- 2
- Bristol-Myers Squibb 7
- 2023 10th
- 2022 18th
- 3
- Bayer 4
- 2023 8th
- 2022 2nd
- 4
- Novo Nordisk 9
- 2023 14th
- 2022 8th
- 5
- Pfizer 2
- 2023 4th
- 2022 3rd
- 6
- Sanofi 1
- 2023 6th
- 2022 9th
- 7
- Boehringer Ingelheim 5
- 2023 3rd
- 2022 4th
- 8
- Johnson & Johnson 6
- 2023 15th
- 2022 7th
- 9
- Merck KGaA 15
- 2023 25th
- 2022 5th
- 10
- Roche 1
Download the report - launching November 4th 2025
IDEA Pharma’s Digital Pharma Invention Index, and the accompanying White Paper, explore the performance of individual companies in much greater detail. By accessing our White Papers, you are given an inside look into our research and findings.
- 1 Methodology and analysis
- 2 Extended profiles of the Top 10 overall companies
- 3 The full top 30 ranking
- 4 The report in full
- 5 Ranking of performance: Commercial, Clinical & Research
Have an opinion?
We’d love to hear your thoughts. We are open to further discussion and encourage questions and comments about our rankings. Please give us a shout to continue the conversation, we are here to answer.
